Immuno-oncology Comes of Age—Introduction
Author:
Open Access
- 1 October 2014
- journal article
- Published by Elsevier in Seminars in Oncology
- Vol. 41, S1-S2
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Advances in immuno-oncology2012
- Immunotherapy of cancer in 2012CA: A Cancer Journal for Clinicians, 2012
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer ImmunotherapyClinical Cancer Research, 2011
- Increased Intensity Lymphodepletion Enhances Tumor Treatment Efficacy of Adoptively Transferred Tumor-specific T CellsJournal of Immunotherapy, 2010
- Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative RegimensJournal of Clinical Oncology, 2008
- Treatment of Metastatic Melanoma Using Interleukin-2 Alone or in Conjunction with VaccinesClinical Cancer Research, 2008
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Interferons in the treatment of human cancer.Journal of Clinical Oncology, 1984